Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Abstract of this article
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Kilby, J. M.
space
  arrow  Bucy, R. P.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

SUMMARIES FOR PATIENTS

Patient Who Became Acutely Ill after Stopping Anti-HIV Treatment

19 September 2000 | Volume 133 Issue 6 | Page I-46

Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.

Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician.

The summary below is from the full report titled "Recurrence of the Acute HIV Syndrome after Interruption of Antiretroviral Therapy in a Patient with Chronic HIV Infection: A Case Report." It is in the 19 September 2000 issue of Annals of Internal Medicine (volume 131, pages 435-438). The authors are JM Kilby, PA Goepfert, AP Miller, JW Gnann Jr., M Sillers, MS Saag, and RP Bucy.


What is the problem and what is known about it so far?
space

Antiretroviral (anti-HIV) therapy consists of combinations of drugs that slow the growth of the virus. Two laboratory tests, CD4 cell count and viral load, help to monitor patients' response to anti-HIV treatment. CD4 count is a measure of immune cells; high CD4 counts are better than low ones. The viral load is the amount of the virus's genetic material in a person's blood; the lower the viral load, the better. It is well known that the virus starts multiplying rapidly throughout the body when an HIV-infected person stops anti-HIV therapy, causing the viral load in the bloodstream to increase. However, an acute illness has not been described in this setting.


Why did the researchers do this particular study?
space

To describe a patient who became acutely ill after stopping anti-HIV treatment.


Who was studied?
space

An adult man with HIV infection.


How was the study done?
space

The researchers described the clinical course, including CD4 cell count and viral load, before and after the patient stopped anti-HIV therapy. They also described studies that they did to rule out other possible causes of the illness.


What did the researchers find?
space

The patient stopped anti-HIV medicines shortly after receiving a shot of influenza (flu) vaccine. Eleven days later, he became ill with fever, muscle aches, fatigue, swollen lymph nodes, vomiting, and diarrhea. These symptoms are very similar to those that affect many people when they are first infected with HIV. The patient's CD4 count decreased from 743 to 164 cells per cubic millimeter. Viral load increased to 327,874 copies per milliliter from a previous level of less than 50 copies per milliliter. Tests did not identify any other cause of the illness. About 3 weeks later, the patient resumed anti-HIV medicines and his symptoms rapidly resolved. Within the next 2 weeks, the viral load decreased to 2743 copies per milliliter and the CD4 cell count increased to more than 500 cells per cubic millimeter.


What were the limitations of the study?
space

This report describes only one patient, so it can't tell us how frequently this kind of acute illness occurs when anti-HIV treatment is stopped. The relationship of the flu vaccine to the illness is uncertain, although flu vaccination does not usually cause symptoms such as these in HIV-infected persons.


What are the implications of the study?
space

It seems that an illness similar to that seen with initial HIV infection, along with a rapid increase in the amount of virus in the blood, can occur with the discontinuation of anti-HIV treatment. Doctors and patients should be aware that this syndrome might occur when patients stop anti-HIV drugs.


Related articles in Annals:

Summaries for Patients
Patient Who Became Acutely Ill after Stopping Anti-HIV Treatment
Annals 2000 133: I-46. [Full Text]  



This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
A. Boschi, C. Tinelli, P. Ortolani, and M. Arlotti
Safety and factors predicting the duration of first and second treatment interruptions guided by CD4+ cell counts in patients with chronic HIV infection
J. Antimicrob. Chemother., March 1, 2006; 57(3): 520 - 526.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
J. G. Prado, A. Shintani, M. Bofill, B. Clotet, L. Ruiz, and J. Martinez-Picado
Lack of Longitudinal Intrapatient Correlation between p24 Antigenemia and Levels of Human Immunodeficiency Virus (HIV) Type 1 RNA in Patients with Chronic HIV Infection during Structured Treatment Interruptions
J. Clin. Microbiol., April 1, 2004; 42(4): 1620 - 1625.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
P.-M. Roger, J. Durant, M. Ticchioni, P. Halfon, J.-P. Breittmayer, C. Brignone, S. Chaillou, B. Dunais, P. Dellamonica, A. Bernard, et al.
Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptions
J. Antimicrob. Chemother., August 1, 2003; 52(2): 269 - 275.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
U. L. Abbas and J. W. Mellors
Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: Risk without reward
PNAS, October 15, 2002; 99(21): 13377 - 13378.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. V. Havlir
Structured intermittent treatment for HIV disease: Necessary concession or premature compromise?
PNAS, January 8, 2002; 99(1): 4 - 6.
[Full Text] [PDF]


Home page
JWatch GeneralHome page
Retroviral Rebound
Journal Watch (General), October 10, 2000; 2000(1010): 2 - 2.
[Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. M. Ortiz, M. Wellons, J. Brancato, H. T. T. Vo, R. L. Zinn, D. E. Clarkson, K. Van Loon, S. Bonhoeffer, G. D. Miralles, D. Montefiori, et al.
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects
PNAS, November 6, 2001; 98(23): 13288 - 13293.
[Abstract] [Full Text] [PDF]


box Article
 arrow  Table of Contents                
space
 arrow  Abstract of this article
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Kilby, J. M.
space
  arrow  Bucy, R. P.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2000 by the American College of Physicians.